Skip to main content

Table 3 The value of Different Clinical-Radiomics Models in Training cohort and Validation cohort

From: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma

 

Train

 

Validation

 

AUC

ACC

95%CI

Sensitivity

Specificity

 

AUC

ACC

95%CI

Sensitivity

Specificity

CT _ clinical

           

GP

0.887

0.824

0.833–0.933

0.820

0.831

 

0.795

0.793

0.635–0.923

0.867

0.714

LR

0.862

0.833

0.798–0.914

0.885

0.774

 

0.810

0.724

0.639–0.916

0.800

0.643

PLS-DA

0.848

0.781

0.782–0.903

0.770

0.792

 

0.800

0.724

0.636–0.914

0.733

0.714

CTE _ clinical

           

GP

0.840

0.781

0.773–0.896

0.820

0.736

 

0.843

0.828

0.697–0.952

0.867

0.786

LR

0.835

0.798

0.760–0.894

0.787

0.811

 

0.843

0.793

0.692–0.949

0.733

0.857

PLS-DA

0.795

0.772

0.717–0.860

0.770

0.773

 

0.824

0.793

0.657–0.938

0.867

0.714

ComB _ clinical

           

GP

0.872

0.798

0.812–0.919

0.738

0.868

 

0.824

0.759

0.676–0.929

0.800

0.714

LR

0.869

0.781

0.811–0.919

0.803

0.736

 

0.833

0.793

0.688–0.938

0.800

0.786

PLS-DA

0.852

0.763

0.789–0.905

0.738

0.717

 

0.843

0.828

0.697–0.952

0.800

0.857

  1. Note. AUC area under the receiver-operating characteristic curve, ACC accuracy, GP gaussian process, LR logistic regression, PLS-DA partial least-squares discrimination analysis, CT computed tomography, CTE CT-enhanced, ComB, the combination of CT_clinical and CTE_clinical models